Promising Early Results from Mesothelioma Vaccine Trial

28161928_blood test3

Researchers studying a new immunotherapy vaccine for mesothelioma have released early findings from an ongoing clinical trial and the results are promising. CRS-207 is based on a genetically modified version of Listeria monocytogenes, a bacterium normally associated with the food borne illness, Listeriosis. The drug was designed to induce a powerful immune response against cells […]

Scrubbed Trial May Not Be the End for Mesothelioma Drug

335415_disappointed patient

The makers of the once-promising experimental mesothelioma drug defactinib have announced that they will stop a clinical trial of the drug early because, by itself, it does not appear to help. But this may not be the end of the road for defactinib in mesothelioma treatment. Defactinib (VS-6063) had been the leading compound for its […]

Mesothelioma Awareness Day Shines Spotlight on the Danger of Asbestos


Organizers of the annual Mesothelioma Awareness Day are encouraging patients, families, advocates and those who have lost loved ones to wear blue on Saturday, September 26th to help bring attention to a disease that kills nearly 3,000 Americans annually and as many as 100,000 around the world. Mesothelioma Awareness Day was organized in 2004 and has […]

Longest Living Mesothelioma Survivor Offers Hope to Observers of Mesothelioma Awareness Day


As mesothelioma patients, advocates and health professionals prepare for the 11th annual Mesothelioma Awareness Day on September 26th, the world’s longest-living documented survivor of mesothelioma is about to celebrate his 71st birthday. It is a milestone that few expected him to see. Australian Paul Kraus is the author of “Surviving Mesothelioma and Other Cancers: A […]

Long Term Mesothelioma Survival with Immune System Activation


A small group of Australian mesothelioma patients have reportedly lived more than twice as long as expected with a combination of standard chemotherapy and immune system manipulation with the CD40 protein. The CD40 protein plays a role in a broad range of immune and inflammatory responses in the body. Studies in mice have found that […]

Could Other Gene Mutations Be Behind Mesothelioma?


A mutation of the BAP1 gene may not be the only reason mesothelioma can sometimes run in families. A more complex genetic picture may also help explain why some asbestos-exposed workers get the disease and some do not. Exposure to asbestos is the number one cause of malignant mesothelioma, an aggressive cancer that starts on […]

Mesothelioma Awareness Day Gets a Boost from Social Media


    Victims of mesothelioma and their families are being invited to make their voices and their stories heard on social media in advance of the 11th annual Mesothelioma Awareness Day on September 26th. The invitation is being extended by the Asbestos Disease Awareness Organization (ADAO), an organization committed to ending the scourge of asbestos […]

Clinical Trial May be Best Second-Line Approach for Mesothelioma

Doctor holding x-ray film

The best second-line treatment for mesothelioma patients who fail to respond to standard chemotherapy is probably to enroll in a clinical trial. The authors of a newly-published paper on the subject reached that conclusion after reviewing the results of 29 studies on potential second- or third-line mesothelioma treatments. Most patients who are diagnosed with mesothelioma, […]

Peritoneal Mesothelioma Rates Higher in Italy’s Asbestos-Producing Regions


Some Italian workers are paying a high price for Italy’s former position as the top European producer of asbestos. According to a new study in the American Journal of Industrial Medicine, both men and women who lived and worked in areas of heavy asbestos production are far more likely than their peers elsewhere in the […]

Support for Three-Prolonged Mesothelioma Treatment Approach


Three treatments are better than one when it comes to malignant pleural mesothelioma. That is the conclusion of a new study conducted by researchers at the University of Washington. The team studied mesothelioma patients who received trimodality therapy with radiation between 1980 and 2011 and found that those who had three types of treatment, instead of […]